≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

Other leukaemias of specified cell type

Endpoint Browser

C3_OTHER_LEUKAEMIA_SPECIFIED

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C94
  • Hospital discharge: ICD-9 — 207[0-8]
  • Hospital discharge: ICD-8 — 207[0-2]
  • Cause of death: ICD-10 — C94
  • Cause of death: ICD-9 — 207[0-8]
  • Cause of death: ICD-8 — 207[0-2]

2 out of 7 registries used, show all original rules.

93

4. Check minimum number of events

None

93

5. Include endpoints

None

93

6. Filter based on genotype QC (FinnGen only)

87

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF8
Parent code in ICD-10
C81-C96
Name in latin
Aliae leuc(h)aemiae typo cellulari specificato

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 87 49 38
Unadjusted period prevalence (%) 0.02 0.02 0.02
Median age at first event (years) 55.66 52.99 59.09

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
93
Matched controls
930
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
35.4
61.0
45
24
127
Kela drug reimbursment
Transplant complication
115.3
34.9
36
5
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
17.4
32.5
31
26
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
13.4
28.2
32
35
C94.0
ICD-10 Finland
Acute erythroid leukaemia
+∞
26.3
24
*
XW000
NOMESCO Finland
Bone marrow biopsy
35.6
25.8
33
14
C94.7
ICD-10 Finland
Other specified leukaemias
+∞
24.0
22
*
L04AA06
ATC
mycophenolic acid; systemic
41.9
20.5
25
8
ZX120
NOMESCO Finland
Intravenous
8.7
20.1
32
53
L04AA01
ATC
[U] ciclosporin
66.8
18.9
21
*
L04AD01
ATC
ciclosporin; systemic
35.4
17.5
22
8
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.5
16.5
36
82
WW500
NOMESCO Finland
Blood transfusion
15.0
14.3
24
21
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
27.4
13.5
18
8
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.4
13.2
35
93
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
81.3
13.0
14
*
L04AD02
ATC
tacrolimus; systemic
81.3
13.0
14
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
44.1
12.6
15
*
Z94.0
ICD-10 Finland
Kidney transplant status
44.1
12.6
15
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
44.1
12.6
15
*
R50.9
ICD-10 Finland
Fever, unspecified
4.9
11.8
36
107
C94.4
ICD-10 Finland
Acute panmyelosis with myelofibrosis
+∞
11.7
11
*
C03CA01
ATC
furosemide; systemic
4.5
11.7
51
199
TK800
NOMESCO Finland
Hemodialysis
23.8
11.6
16
8
J01MA12
ATC
levofloxacin; systemic
4.8
11.6
35
103
Z3226
NOMESCO Finland
Physiotherapist
4.7
11.4
37
115
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
68.0
10.9
12
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
68.0
10.9
12
*
C94.1
ICD-10 Finland
Chronic erythremia
+∞
10.6
10
*
Z3231
NOMESCO Finland
Registered nurse
4.2
10.6
48
190
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.6
10.5
67
336
M04AA01
ATC
allopurinol; systemic
5.2
10.3
26
65
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
5.0
10.3
27
70
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
23.2
10.2
14
7
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.1
10.1
26
66
H02AB09
ATC
hydrocortisone; systemic
13.6
10.1
17
15
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
61.6
9.9
11
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
61.6
9.9
11
*
J01MA14
ATC
moxifloxacin; systemic
5.9
9.8
20
41
B03XA01
ATC
erythropoietin; parenteral
110.8
9.6
10
*
C94.2
ICD-10 Finland
Acute megakaryoblastic leukaemia
+∞
9.5
9
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.5
9.4
21
47
Z2221
NOMESCO Finland
Medical doctor
3.9
9.3
43
169
Z2446
NOMESCO Finland
Social worker
5.7
9.3
20
43
R4110
NOMESCO Finland
Physiotherapy
3.8
9.3
44
176
H02AB04
ATC
methylprednisolone; systemic
4.4
9.3
29
86
A12AA04
ATC
calcium carbonate; oral
41.1
9.2
11
*
ZX108
NOMESCO Finland
Inhalation
41.1
9.2
11
*
A11CC03
ATC
alfacalcidol; systemic
21.3
9.2
13
7
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
9.3
9.2
19
25
L03AA02
ATC
filgrastim; parenteral
11.8
8.9
16
16
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
55.4
8.9
10
*
N18.0
ICD-10 Finland
End-stage renal disease
55.4
8.9
10
*
TGC00
NOMESCO Finland
Bronchial lavation
18.6
8.8
13
8
L01BB02
ATC
mercaptopurine; oral
30.8
8.7
11
*
C94.5
ICD-10 Finland
Acute myelofibrosis
+∞
8.5
8
*
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
+∞
8.5
8
*
6BA02, ,
NOMESCO Finland
+∞
8.5
8
*
Z94.1
ICD-10 Finland
Heart transplant status
+∞
8.5
8
*
L04AX01
ATC
azathioprine; systemic
10.5
8.4
16
18
A05AA02
ATC
ursodeoxycholic acid; oral
19.4
8.3
12
7
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
36.9
8.3
10
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
7.7
8.3
19
30
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
9.9
8.2
16
19
Z3229
NOMESCO Finland
Other healthcare associate professional
5.2
8.1
19
44
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
10.3
7.9
15
17
D07AB08
ATC
desonide; topical
4.8
7.8
20
50
N18.8
ICD-10 Finland
Other chronic renal failure
20.5
7.8
11
6
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
86.7
7.5
8
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
86.7
7.5
8
*
ZXE10
NOMESCO Finland
More than one and less than three hours
3.3
7.5
46
212
J02AC03
ATC
voriconazole; systemic
+∞
7.4
7
*
GD1AD
NOMESCO Finland
Thorax CT examination
8.2
7.4
16
23
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
8.7
7.2
15
20
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
7.8
7.2
16
24
TAB00
NOMESCO Finland
Lumbar puncture
7.8
7.2
16
24
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
43.3
6.9
8
*
137
Kela drug reimbursment
Uraemia requiring dialysis
24.6
6.8
9
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
24.6
6.8
9
*
B03XA02
ATC
darbepoetin alfa; parenteral
13.6
6.8
11
9
TPX10
NOMESCO Finland
Implantation of vascular injection port
11.3
6.8
12
12
ZXD05
NOMESCO Finland
Urgent procedure
3.2
6.7
39
172
Z94.4
ICD-10 Finland
Liver transplant status
74.8
6.5
7
*
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
74.8
6.5
7
*
B07.9
ICD-10 Finland
Verruca simplex
10.4
6.5
12
13
J05AB01
ATC
aciclovir; systemic
3.3
6.5
33
134
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.5
6.4
28
103
TPH04
NOMESCO Finland
Cathetrisation of vein
3.2
6.4
33
135
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
+∞
6.3
6
*
196
Kela drug reimbursment
Paricalcitol and cinacalcet
+∞
6.3
6
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
6.3
6
*
20700
ICD-8 Finland
Other and unspecified leukaemia, Leukaemia, acute
+∞
6.3
6
*
ZXA00
NOMESCO Finland
Right side
3.1
6.2
36
157
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
8.2
6.2
13
18

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
24
14
22.58
16.72
1.5
1.4
—
—
—
0
0
33
74
6.36
15.23
6.1
4.1
69.72
66.73
e9/l
0.20
22
58
36
97
5.42
13.43
8.9
4.2
1.90
1.58
%
1.35
36
89
45
149
4.91
13.04
11.8
3.8
0.79
0.82
mmol/l
0.76
45
139
17
8
25.57
12.55
1.4
1.3
—
—
—
0
0
59
249
4.75
12.32
17.7
4.4
7.39
7.40
ph
0.50
50
187
23
31
9.49
11.05
1.5
1.4
—
—
—
0
0
15
9
19.54
10.27
1.4
1.0
—
—
—
0
0
60
284
4.14
10.09
19.2
5.9
—
—
—
0
0
53
239
3.83
9.39
12.4
4.5
—
—
—
0
0
14
10
16.21
9.03
1.8
1.4
—
—
—
0
0
73
416
4.51
8.99
28.2
7.9
1.21
1.21
mmol/l
0.27
68
365
32
108
3.99
8.55
2.5
1.4
—
—
—
0
0
36
132
3.82
8.54
6.0
2.4
2.10
2.32
g/l
1.02
36
123
8
0
+∞
8.45
1.0
0.0
—
—
—
0
0
33
117
3.82
8.18
6.6
2.5
27.22
23.94
%
0.47
33
112
71
413
4.04
8.11
22.2
5.9
55.22
57.23
%
0.54
71
398
25
76
4.13
7.63
14.2
3.2
1.58
0.93
%
0.70
19
30
25
77
4.07
7.49
2.1
1.3
—
—
—
0
0
35
137
3.49
7.39
6.3
2.5
12.67
14.27
umol/l
0.65
35
131
7
0
+∞
7.38
1.3
0.0
—
—
—
0
0
26
85
3.86
7.15
12.7
8.3
—
—
—
0
0
23
70
4.04
6.97
14.1
3.3
0.47
0.17
%
0.85
17
24
29
104
3.60
6.95
2.4
1.7
—
—
—
0
0
23
71
3.98
6.83
1.6
1.4
—
—
—
0
0
75
490
3.74
6.38
32.0
10.3
3.80
4.07
e9/l
0.35
70
422
11
11
11.15
6.22
5.9
2.2
30.80
42.85
%
1.13
11
11
29
113
3.28
6.03
11.6
7.9
104.59
104.33
mmol/l
0.11
29
113
37
168
3.00
5.92
2.5
1.8
—
—
—
0
0
51
284
2.76
5.47
7.7
2.6
—
—
—
0
0
24
90
3.25
5.25
9.5
3.6
5.31
4.82
kpa
0.48
24
90
68
445
2.96
5.25
21.6
6.2
0.64
0.59
e9/l
0.29
63
385
61
378
2.78
5.22
33.1
11.0
0.02
0.01
e9/l
0.44
49
291
68
447
2.94
5.17
21.4
6.2
0.04
0.04
e9/l
0.03
63
386
52
299
2.68
5.14
6.8
3.4
35.03
37.78
e6/l
0.04
46
221
32
144
2.86
5.10
2.6
1.6
—
—
—
0
0
20
68
3.47
5.09
13.0
3.2
1.08
0.58
%
0.48
13
24
26
105
3.05
5.01
10.4
4.6
5.51
5.62
kpa
0.20
26
105
9
10
9.81
4.90
1.9
1.9
3.18
3.97
mg/l
—
9
10
62
397
2.69
4.81
8.5
3.0
—
—
estimate
—
0
0
48
273
2.57
4.75
20.7
5.9
—
—
—
0
0
32
149
2.75
4.74
5.6
3.0
1.43
1.99
e6/l
0.22
18
78
46
259
2.54
4.62
6.0
3.3
0.19
0.41
e6/l
0.92
39
181
9
12
8.16
4.47
1.1
1.0
—
—
—
0
0
28
128
2.70
4.25
3.7
2.1
—
—
—
0
0
10
18
6.08
4.10
3.1
1.4
—
—
—
0
0
10
18
6.08
4.10
3.1
1.4
—
—
—
0
0
10
18
6.08
4.10
3.1
1.4
—
—
—
0
0
10
18
6.08
4.10
3.1
1.4
—
—
—
0
0
24
103
2.79
4.09
11.2
5.0
7.35
7.39
ph
0.43
18
73
7
7
10.68
4.08
7.7
1.4
190.14
131.43
e6/l
—
7
7
18
66
3.14
4.03
9.7
3.5
23.29
23.75
mmol/l
0.21
18
66
44
256
2.36
3.97
4.0
3.3
—
—
—
0
0
19
73
3.01
3.93
14.5
3.5
0.38
0.40
%
0.01
13
25
57
378
2.31
3.72
30.5
12.0
1.29
1.21
inr
0.53
47
315
65
456
2.41
3.71
26.9
7.2
11.72
11.63
umol/l
0.02
65
432
15
52
3.25
3.66
10.6
10.7
0.60
0.59
%
0.02
15
52
22
96
2.69
3.61
8.4
8.2
7.42
7.42
ph
0.09
12
63
15
53
3.18
3.55
10.6
10.5
1.36
1.42
%
0.06
15
53
52
337
2.23
3.52
8.6
4.1
73.63
74.55
e6/l
0.01
44
228
15
54
3.12
3.44
6.1
3.1
—
—
—
0
0
7
10
7.46
3.43
2.6
1.4
—
—
—
0
0
35
203
2.16
3.03
4.1
1.5
2.06
2.28
g/l
0.28
27
114
21
98
2.48
2.99
2.8
1.4
—
—
—
0
0
42
264
2.08
2.94
6.4
4.1
30.54
9.45
mg/mmol
0.98
30
167
6
9
7.03
2.91
1.3
1.0
—
—
—
0
0
7
14
5.31
2.78
1.1
1.0
—
—
—
0
0
8
19
4.50
2.74
1.4
1.2
278.09
22.57
u/l
—
8
14
6
10
6.32
2.74
2.5
5.3
—
—
—
0
0
39
245
2.02
2.68
1.9
1.5
—
—
—
0
0
42
271
2.00
2.68
7.2
3.4
2.31
2.36
mmol/l
1.08
42
245
7
15
4.95
2.65
8.0
1.3
—
—
—
0
0
10
31
3.49
2.61
10.7
6.7
37.00
37.03
°c
—
10
31
42
275
1.96
2.54
6.1
3.5
5.32
7.96
mmol/l
4.92
37
236
7
17
4.36
2.41
2.3
1.3
—
—
—
0
0
49
347
1.87
2.28
2.0
2.1
86.56
95.77
pmol/l
0.68
29
170
59
444
1.90
2.26
7.2
3.8
0.00
0.00
estimate
-0.00
14
90
59
446
1.88
2.21
7.2
3.8
0.00
0.00
estimate
-0.00
14
91
7
19
3.89
2.19
8.4
1.1
55.00
2.31
e6/l
—
7
13
7
19
3.89
2.19
8.4
1.2
64.29
374.54
e6/l
—
7
13
39
260
1.86
2.17
6.1
3.4
101.98
51.20
mg/l
0.49
29
168
11
43
2.76
2.17
2.4
1.3
—
—
—
0
0
50
361
1.83
2.15
5.3
3.4
6.65
6.22
ph
1.58
27
195
8
25
3.40
2.15
2.0
1.3
0.88
0.92
g/l
—
8
25
59
449
1.86
2.13
7.3
3.9
0.00
0.00
estimate
-0.00
14
85
7
20
3.70
2.10
5.4
2.2
—
—
—
0
0
5
10
5.21
2.10
2.0
2.0
34.40
31.70
pg
—
5
10
45
319
1.80
2.02
3.0
1.9
—
—
—
0
0
30
188
1.88
1.99
17.2
5.4
—
—
—
0
0
6
16
3.93
1.97
2.2
1.3
—
—
—
0
0
76
636
2.07
1.96
30.1
8.5
93.24
85.26
u/l
0.51
76
600
7
22
3.35
1.92
6.7
3.1
50.29
56.75
%
—
7
22
5
12
4.34
1.84
2.2
2.1
0.15
0.47
nmol/l
—
5
7
6
18
3.49
1.77
6.2
3.1
3.51
4.60
e9/l
—
6
18
7
25
2.94
1.68
1.6
1.2
—
—
—
0
0
14
72
2.11
1.59
11.6
7.7
23.66
25.22
mmol/l
0.81
14
72
35
245
1.69
1.56
8.3
3.9
0.00
0.00
estimate
—
7
81
6
22
2.84
1.46
7.0
3.2
7.42
7.41
ph
—
6
22
18
281
0.55
1.42
2.2
3.3
—
—
—
0
0
6
23
2.72
1.39
2.5
1.2
—
—
—
0
0
0
39
0.00
1.37
0.0
1.1
—
—
—
0
0
8
35
2.40
1.30
7.5
3.5
28.75
1225.44
u/ml
—
8
27
11
56
2.09
1.28
8.7
3.2
—
—
—
0
0
5
19
2.72
1.23
6.4
1.5
3.84
7.82
u/ml
—
5
19
11
57
2.05
1.23
21.8
5.1
1.23
1.22
mmol/l
0.20
11
49
42
328
1.51
1.12
7.6
3.7
0.14
0.00
estimate
0.47
14
75
17
106
1.74
1.12
1.8
1.2
—
—
—
0
0
14
83
1.81
1.09
1.3
1.3
—
—
—
0
0
16
99
1.74
1.08
5.6
3.5
6.58
4.38
e9/l
0.41
16
87
10
53
1.99
1.06
1.8
2.8
276.20
278.94
ng/l
—
10
47
6
28
2.22
0.93
1.3
1.2
—
—
—
0
0
6
32
1.93
0.83
2.3
1.2
—
—
—
0
0
8
47
1.77
0.83
1.1
1.2
—
—
—
0
0
0
24
0.00
0.80
0.0
1.1
—
9.19
—
0
19
0
24
0.00
0.80
0.0
1.1
—
0.75
—
0
19
0
26
0.00
0.80
0.0
1.1
—
0.13
—
0
18
5
23
2.24
0.77
8.2
5.4
3.80
3.98
mmol/l
—
5
23
9
54
1.74
0.77
5.9
5.3
—
—
—
0
0
5
26
1.97
0.72
3.4
1.5
59.00
38.15
nmol/l
—
5
26
5
27
1.90
0.69
3.6
3.9
83.64
60.18
%
—
5
27
25
192
1.41
0.69
9.9
3.7
1.01
1.02
kg/l
2.05
19
126
5
28
1.83
0.67
2.6
3.4
1.10
1.54
mmol/l
—
5
28
11
71
1.62
0.65
2.3
1.4
—
—
—
0
0
6
36
1.71
0.58
5.3
3.9
376.33
197.25
mg/l
—
6
16
6
40
1.53
0.52
1.2
1.2
—
—
—
0
0
29
239
1.31
0.51
6.9
3.3
2.09
0.00
estimate
0.56
11
70
7
46
1.56
0.49
1.1
2.1
—
8.83
—
0
9
78
818
0.71
0.48
41.9
14.4
—
—
—
0
0
13
97
1.40
0.42
1.3
1.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
2.2
—
3.87
—
0
11
0
17
0.00
0.41
0.0
1.0
—
0.56
—
0
10
0
17
0.00
0.41
0.0
1.1
—
1.46
—
0
9
18
217
0.79
0.34
1.1
1.5
1.60
0.99
u/ml
—
5
56
23
267
0.82
0.31
4.8
3.8
—
—
—
0
0
8
61
1.34
0.29
4.4
4.3
—
—
—
0
0
9
75
1.22
0.26
11.8
4.6
7.40
7.37
ph
—
9
55
72
748
0.83
0.24
6.6
5.0
5.81
5.92
mmol/l
0.36
66
692
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
11
90
1.25
0.20
2.6
1.7
—
—
—
0
0
72
744
0.86
0.19
5.8
5.4
2.19
1.85
mu/l
1.12
67
686
12
102
1.20
0.16
1.0
1.2
—
—
—
0
0
9
78
1.17
0.16
8.0
2.3
5.61
6.08
ph
—
9
50
35
327
1.11
0.14
7.6
3.6
39.64
37.64
ng/l
0.05
29
227
5
44
1.14
0.10
2.0
1.6
—
0.34
—
0
18
13
143
0.89
0.08
1.2
1.3
4.10
7.04
u/ml
—
7
53
14
153
0.90
0.08
1.1
1.3
16.30
38.38
iu/ml
—
7
54
0
5
0.00
0.00
0.0
1.0
—
169.40
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
-0.00
1.4
1.2
—
32.90
—
0
5
0
6
0.00
-0.00
0.0
2.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.0
—
—
—
0
0
7
76
0.91
-0.00
1.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_OTHER_LEUKAEMIA_SPECIFIED – Other leukaemias of specified cell type

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).